Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-823778 in overweight and obese subjects with inadequately controlled hypertension
2012-000509-54Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bms-823778 in hypertension (HTN) (4 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Change in 24-hour ambulatory diastolic blood pressure. Started Jul 2012; status: completed.
02
Drugs
bms-823778
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2012-000509-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000509-54.